Bile acid dysmetabolism in inflammatory bowel diseases

Aim: To summarize the state-of-the-art data on the molecular mechanisms of bile acid (BA) synthesis and absorption, their impaired absorption and receptor-dependent signaling, as well as on the effects of the gut microbiota on BA metabolism in inflammatory bowel diseases (IBD). Key messages: BA m...

Full description

Bibliographic Details
Main Authors: Daria A. Kuznetsova, Sergey V. Lapin, Irina V. Gubonina
Format: Article
Language:Russian
Published: MONIKI 2023-05-01
Series:Alʹmanah Kliničeskoj Mediciny
Subjects:
Online Access:https://almclinmed.ru/jour/article/viewFile/7708/1552
_version_ 1797828641919336448
author Daria A. Kuznetsova
Sergey V. Lapin
Irina V. Gubonina
author_facet Daria A. Kuznetsova
Sergey V. Lapin
Irina V. Gubonina
author_sort Daria A. Kuznetsova
collection DOAJ
description Aim: To summarize the state-of-the-art data on the molecular mechanisms of bile acid (BA) synthesis and absorption, their impaired absorption and receptor-dependent signaling, as well as on the effects of the gut microbiota on BA metabolism in inflammatory bowel diseases (IBD). Key messages: BA malabsorption is one of the relevant mechanisms in the development of diarrhea in IBD. It may occur due to various disorders of the ileum, such as terminal ileitis, ileocolitis or ileocecal resection in Crohn's disease and ileoanal reservoir in ulcerative colitis. Molecular mechanisms of BA malabsorption in IBD are related to a defect in the BA uptake by the apical sodium dependent bile acid transporter (ASBT), as well as to a decrease in the expression of pregnane X receptor (PXR) and farnesoid X receptor (FXR), whose activation by glucocorticoids results in an increase in the BA reabsorption in the ileum and a decrease in hologenic diarrhea. The metabolic profile of luminal BA in IBD is characterized by an increased content of conjugated and 3-OH-sulfated BA and reduced levels of secondary BA. The decrease in the relative abundance of the Lachnospiraceae and Oscillospiraceae spp. in IBD patients leads to a decrease in the efficiency of microbial biotransformation of BA. Changes in the BA metabolic profile in IBD affect the gut microbiota, and impaired interaction with the FXR, PXR, G protein-coupled bile acid receptor (GPBAR1), retinoid-related orphan receptors (RORs) and vitamin D receptor (VDR) results in a pro-inflammatory response and increased intestinal permeability, bacterial translocation, and IBD progression. BA metabolism in IBD-associated primary sclerosing cholangitis (PSC-IBD) is characterized by a significant decrease in the luminal BA pool, and the microbiota composition is remarkable for an increase in the relative abundance of Fusobacterium and Ruminococcus spp., and a decrease in Veillonella, Dorea, Blautia, Lachnospira and Roseburia. Conclusion: Disordered synergistic interplay of BA with intestinal microbiota results in disruption of the ligand-receptor interaction and BA metabolic transformation, which contributes to the activation of the immune system, formation of a vicious circle of chronic inflammation and IBD progression. Further studies into mutual influence of the gut microbiota, BA metabolism and receptor signaling may promote the development of new methods for the diagnosis and treatment of IBD.
first_indexed 2024-04-09T13:07:36Z
format Article
id doaj.art-0722b5abd4e448d493e75059352c32df
institution Directory Open Access Journal
issn 2072-0505
2587-9294
language Russian
last_indexed 2024-04-09T13:07:36Z
publishDate 2023-05-01
publisher MONIKI
record_format Article
series Alʹmanah Kliničeskoj Mediciny
spelling doaj.art-0722b5abd4e448d493e75059352c32df2023-05-12T10:29:47ZrusMONIKIAlʹmanah Kliničeskoj Mediciny2072-05052587-92942023-05-0151111310.18786/2072-0505-2023-51-007924Bile acid dysmetabolism in inflammatory bowel diseasesDaria A. Kuznetsova0https://orcid.org/0000-0001-5318-354XSergey V. Lapin1https://orcid.org/0000-0002-4998-3699Irina V. Gubonina2https://orcid.org/0000-0002-6302-7767Academician I.P. Pavlov First St. Petersburg State Medical UniversityAcademician I.P. Pavlov First St. Petersburg State Medical UniversityMilitary Medical Academy named after S.M. KirovAim: To summarize the state-of-the-art data on the molecular mechanisms of bile acid (BA) synthesis and absorption, their impaired absorption and receptor-dependent signaling, as well as on the effects of the gut microbiota on BA metabolism in inflammatory bowel diseases (IBD). Key messages: BA malabsorption is one of the relevant mechanisms in the development of diarrhea in IBD. It may occur due to various disorders of the ileum, such as terminal ileitis, ileocolitis or ileocecal resection in Crohn's disease and ileoanal reservoir in ulcerative colitis. Molecular mechanisms of BA malabsorption in IBD are related to a defect in the BA uptake by the apical sodium dependent bile acid transporter (ASBT), as well as to a decrease in the expression of pregnane X receptor (PXR) and farnesoid X receptor (FXR), whose activation by glucocorticoids results in an increase in the BA reabsorption in the ileum and a decrease in hologenic diarrhea. The metabolic profile of luminal BA in IBD is characterized by an increased content of conjugated and 3-OH-sulfated BA and reduced levels of secondary BA. The decrease in the relative abundance of the Lachnospiraceae and Oscillospiraceae spp. in IBD patients leads to a decrease in the efficiency of microbial biotransformation of BA. Changes in the BA metabolic profile in IBD affect the gut microbiota, and impaired interaction with the FXR, PXR, G protein-coupled bile acid receptor (GPBAR1), retinoid-related orphan receptors (RORs) and vitamin D receptor (VDR) results in a pro-inflammatory response and increased intestinal permeability, bacterial translocation, and IBD progression. BA metabolism in IBD-associated primary sclerosing cholangitis (PSC-IBD) is characterized by a significant decrease in the luminal BA pool, and the microbiota composition is remarkable for an increase in the relative abundance of Fusobacterium and Ruminococcus spp., and a decrease in Veillonella, Dorea, Blautia, Lachnospira and Roseburia. Conclusion: Disordered synergistic interplay of BA with intestinal microbiota results in disruption of the ligand-receptor interaction and BA metabolic transformation, which contributes to the activation of the immune system, formation of a vicious circle of chronic inflammation and IBD progression. Further studies into mutual influence of the gut microbiota, BA metabolism and receptor signaling may promote the development of new methods for the diagnosis and treatment of IBD.https://almclinmed.ru/jour/article/viewFile/7708/1552bile acidsbile acid metabolismbile acid malabsorptiongut microbiotafxrgpbar1pxrrorγtvdrinflammatory bowel diseases
spellingShingle Daria A. Kuznetsova
Sergey V. Lapin
Irina V. Gubonina
Bile acid dysmetabolism in inflammatory bowel diseases
Alʹmanah Kliničeskoj Mediciny
bile acids
bile acid metabolism
bile acid malabsorption
gut microbiota
fxr
gpbar1
pxr
rorγt
vdr
inflammatory bowel diseases
title Bile acid dysmetabolism in inflammatory bowel diseases
title_full Bile acid dysmetabolism in inflammatory bowel diseases
title_fullStr Bile acid dysmetabolism in inflammatory bowel diseases
title_full_unstemmed Bile acid dysmetabolism in inflammatory bowel diseases
title_short Bile acid dysmetabolism in inflammatory bowel diseases
title_sort bile acid dysmetabolism in inflammatory bowel diseases
topic bile acids
bile acid metabolism
bile acid malabsorption
gut microbiota
fxr
gpbar1
pxr
rorγt
vdr
inflammatory bowel diseases
url https://almclinmed.ru/jour/article/viewFile/7708/1552
work_keys_str_mv AT dariaakuznetsova bileaciddysmetabolismininflammatoryboweldiseases
AT sergeyvlapin bileaciddysmetabolismininflammatoryboweldiseases
AT irinavgubonina bileaciddysmetabolismininflammatoryboweldiseases